Edition:
United States

Dishman Pharmaceuticals and Chemicals Ltd (DISH.NS)

DISH.NS on National Stock Exchange of India

302.55INR
6:29am EDT
Change (% chg)

Rs23.85 (+8.56%)
Prev Close
Rs278.70
Open
Rs300.00
Day's High
Rs321.50
Day's Low
Rs287.75
Volume
13,628,604
Avg. Vol
895,423
52-wk High
Rs321.50
52-wk Low
Rs127.95

Latest Key Developments (Source: Significant Developments)

Dishman Pharmaceuticals and Chemicals says no production impact in Bavla units
Wednesday, 8 Mar 2017 12:55am EST 

Dishman Pharmaceuticals and Chemicals Ltd :No impact on the production in any of the other units located at Bavla facility due to fire.  Full Article

Dishman Pharmaceuticals and Chemicals says fire incident at unit at Bavla facility brought under control
Tuesday, 7 Mar 2017 09:40pm EST 

Dishman Pharmaceuticals And Chemicals Ltd : Fire incident at one of units (unit no.7) at Bavla facility on Tuesday and it had been brought under control . Says do not see any major financial impact due to incident .Says company has an insurance policy for the assets damage and the loss of profit.  Full Article

Dishman Pharmaceuticals Sept-qtr consol profit nearly doubles
Thursday, 27 Oct 2016 03:27am EDT 

Dishman Pharmaceuticals & Chemicals Ltd : Consol sept quarter net profit 546.8 million rupees . Consol sept quarter total income from operations 4.37 billion rupees .Consol net profit in sept quarter last year was 277.3 million rupees as per Ind-AS; consol total income from operations was 3.80 billion rupees.  Full Article

Dishman Pharma June-qtr consol profit up about 14 pct
Wednesday, 3 Aug 2016 04:27am EDT 

Dishman Pharmaceuticals and Chemicals Ltd : June-quarter consol net profit 455.1 million rupees . June-quarter consol net sales 3.66 billion rupees . Consol net profit in June quarter last year was 400.2 million rupees as per Ind-AS; consol net sales was 4 billion rupees .  Full Article

Dishman Pharmaceuticals And Chemicals says co's Switzerland arm successfully completes USFDA inspection for 2 units
Thursday, 14 Jul 2016 02:14am EDT 

Dishman Pharmaceuticals and Chemicals Ltd : Co's site at Naroda and Carbogen Amcis AG's sites at Aarau, Neuland successfully pass USFDA inspection . Company's site at Naroda had also successfully completed USFDA inspection and received the Establishment Inspection Report . Sites at Aarau and Neuland completed US FDA inspection without adverse observations and got EIR for the same .  Full Article

Dishman Pharma to sell investment in Schutz Dishman Biotech
Thursday, 19 May 2016 04:52am EDT 

Dishman Pharmaceuticals and Chemicals Ltd : It was decided to sell investment made by in schutz Dishman biotech . To transfer equity stake in co's unit carbogen amcis Shanghai co to another unit Dishman pharma solulions ag .  Full Article

Dishman Pharma March-qtr consol profit up about 29 pct
Thursday, 19 May 2016 04:29am EDT 

Dishman Pharmaceuticals and Chemicals Ltd : March-quarter consol net profit 499.2 million rupees versus net profit of 386.1 million rupees year ago . March-quarter consol net sales 4.06 billion rupees versus 4.21 billion rupees year ago .  Full Article

Dishman Pharmaceuticals and Chemicals Ltd declares Interim dividend
Thursday, 10 Mar 2016 02:43am EST 

Dishman Pharmaceuticals and Chemicals Ltd:Declares Interim dividend of 2.00 Indian rupees (i.e. @ of 100%) per equity share on 8,06,97,136 equity shares of 2.00 Indian rupees each of the company for the financial year 2015-2016.Says interim dividend shall be paid to the members entitled thereto, on and from March 22, 2016.Says dividend cheques/warrants would be posted on or after March 22, 2016.  Full Article

Dishman Pharmaceuticals and Chemicals Ltd's board recommends Bonus Issue
Wednesday, 24 Feb 2016 09:35pm EST 

Dishman Pharmaceuticals and Chemicals Ltd:Recommended bonus issue of equity shares in ratio of one equity share for every one equity share held, as on record date to be determined by the board.Says bonus issue of equity shares will be subject to approval by the shareholders, through postal ballot and the record date will be announced separately.  Full Article

Dishman Pharmaceuticals and Chemicals Ltd says hasn't received any USFDA warnings on Clovis issue
Monday, 16 Nov 2015 09:44pm EST 

Dishman Pharmaceuticals and Chemicals Ltd:Clarifies on news item "USFDA gives warning letter to Dishman due to Clovis issues".Co has not received any USFDA warnings or any communication due to Clovis issue.  Full Article

More From Around the Web

BRIEF-Dishman Pharma & Chemicals Dec-qtr consol profit up about 13 pct

* Consol net profit in Dec quarter last year was 447.6 million rupees as per Ind-AS; consol net sales was 3.86 billion rupees Source text: http://bit.ly/2l6yJi4

No consensus analysis data available.